0002025735-24-000001.txt : 20240621 0002025735-24-000001.hdr.sgml : 20240621 20240621114620 ACCESSION NUMBER: 0002025735-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 EFFECTIVENESS DATE: 20240621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspicio Therapeutics, Inc. CENTRAL INDEX KEY: 0002025735 ORGANIZATION NAME: IRS NUMBER: 990883354 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-516565 FILM NUMBER: 241058967 BUSINESS ADDRESS: STREET 1: 250 TRUMAN WAY CITY: DOWNINGTON STATE: PA ZIP: 19335 BUSINESS PHONE: 484.885.4744 MAIL ADDRESS: STREET 1: 250 TRUMAN WAY CITY: DOWNINGTON STATE: PA ZIP: 19335 D 1 primary_doc.xml X0708 D LIVE 0002025735 Aspicio Therapeutics, Inc. 250 TRUMAN WAY DOWNINGTON PA PENNSYLVANIA 19335 484.885.4744 DELAWARE None None Corporation true 2024 Michael Keane 250 Truman Way Downingtown PA PENNSYLVANIA 19335 Executive Officer Director Other Health Care Decline to Disclose 06b false 2024-06-18 false true true false 0 400000 400000 0 false 3 0 0 0 false Aspicio Therapeutics, Inc. Michael Keane Michael Keane President 2024-06-21